Is Disc Medicine, Inc. (IRON) a Buy, Sell, or Hold?
Disc Medicine, Inc.
NASDAQ:IRON
$75.01 USD
-$0.97 (-1.28%)
- Volume
- 362.83K
- Average Volume
- 572.34K
- Market Capitalization
- $2.87B
- P/E Ratio
- -11.30
- Dividend Yield
- 0.00%
- Price Target
- $100.00
- Year High
- $99.50
- Year Low
- $40.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.00
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | John D. Quisel |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | IRON |
| CUSIP | 254604101 |
| CIK | 0001816736 |
| Web | https://www.discmedicine.com |
| Phone | 617 674 9274 |
| Currency | USD |
| Employees | 155 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.05 |
| Payout Ratio | 0.00 |
| Current Ratio | 24.00 |
| Quick Ratio | 24.00 |
| Cash Ratio | 2.86 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -5.23 |
| Price / Cash Flow | -14.23 |
| Price / Book | 4.19 |
Price Target and Rating
| Average Stock Price Forecast | $100.00 |
| High Stock Price Forecast | $125.00 |
| Low Stock Price Forecast | $85.00 |
| Forecast Upside/Downside | -24.99% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 11 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-6.01 |
| Trailing P/E Ratio | -11.30 |
| PEG Ratio | 0.25 |
| P/E Growth | 0.25 |
| Net Income | $-212.18M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | -36.95% |
| Return on Assets | -32.20% |
Financials Score
| AltmanZ Score | 26.83 |
| Piotroski Score | 1.00 |
| Working Capital | 716.31M |
| Total Assets | 750.21M |
| Ebit | -238.6M |
| Market Cap | 2.86B |
| Total Liabilities | 61.78M |
Poll Results
About Disc Medicine, Inc. (NASDAQ:IRON) Stock
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis. ...
2026-07-14 14:45:00
NEW YORK, July 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Ironveld shares jump 32% at 0.025p as processing plant hits sustained production
2026-07-14 05:40:10
Shares in Ironveld PLC (AIM:IRON) jumped 32% to 0.025p after the mining developer said its processing plant had reached sustained production and secured strong commercial demand. Ironveld, an AIM-listed company producing strategic metals for mineral processing, said its dense media separation plant was now running continuously for 16 hours a day on a double shift.
2026-07-12 16:11:00
New York, New York--(Newsfile Corp. - July 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-11 15:01:00
NEW YORK, July 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
2026-07-10 14:17:53
New York, New York--(Newsfile Corp. - July 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-10 03:33:00
NEW YORK, July 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. So What: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
2026-07-08 20:01:00
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.
2026-07-07 17:12:00
New York, New York--(Newsfile Corp. - July 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Disc Medicine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Frequently Asked Questions
-
What is the current Disc Medicine, Inc. (IRON) stock price?
-
Disc Medicine, Inc.(NASDAQ:IRON) stock price is $75.01 in the last trading session. During the trading session, IRON stock reached the peak price of $99.5 while $40 was the lowest point it dropped to. The percentage change in IRON stock occurred in the recent session was --1.28% while the dollar amount for the price change in IRON stock was -$-0.97.
-
IRON's industry and sector of operation?
-
The NASDAQ listed IRON is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IRON?
-
William Jacob Savage | Chief Medical Officer
Pamela Stephenson | Chief Commercial Officer
Lisa Amaya Price | Chief Human Resources Officer
Jonathan Yu | Chief Opearating Officer
Rahul Rajan Kaushik | Chief Technical Officer -
How many employees does IRON have?
-
Number of IRON employees currently stands at 155. IRON operates from 321 Arsenal Street, Watertown, MA 02472, US.
-
Link for IRON official website?
-
Official Website of IRON is: https://www.discmedicine.com
-
How do I contact IRON?
-
IRON could be contacted at phone #617 674 9274 and can also be accessed through its website. IRON operates from 321 Arsenal Street, Watertown, MA 02472, US.
-
How many shares of IRON are traded daily?
-
The average number of IRON shares traded daily for last 3 months was 572.34K.
-
What is the market cap of IRON currently?
-
The market value of IRON currently stands at $2.87B with its latest stock price at $75.01